Dr. David A. Paslin, MD

Dr. Paslin practices at Affiliates In Dermatology in Oakland, California.

Dr. Paslin's NPI, 1477650901, was assigned on September 19, 2006. Dr. Paslin graduated from David Geffen School of Medicine at UCLA in 1967. Dr. Paslin's California license number on file is A22970.

Dr. Paslin's primary practice is Affiliates in Dermatology, at 460 34th St, Oakland, CA 94609-2820. The practice phone is (510) 652-8091.

Dr. Paslin's primary practice is Affiliates In Dermatology in Oakland, California. The medical group on file is Affiliates In Dermatology. Dmand AI also links Dr. Paslin to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paslin practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Paslin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Paslin is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Paslin's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acne, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes, psoriasis and scalp rash among the conditions Dr. Paslin treats.

CMS data shows 766 Medicare services from Dr. Paslin across 9 procedure codes in 2024, for 254 Medicare patients. Medicare paid $47,653 for them. Every service was in an office.

CMS counts 254 Medicare patients who saw Dr. Paslin in 2024. The largest group is 75 to 84, with 113 patients. 74% of them have high cholesterol, and 59% have high blood pressure. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Paslin's median patient age at 65, with 36% women.

In 2024, Dr. Paslin wrote 264 Medicare Part D claims for 128 patients. 91% of them were for generic drugs. CMS names the drug for 136 of them, across 6 drugs with 11 or more claims each, at $5,111 in total drug cost. In 2023, CMS named 200 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Paslin for performance year 2024, reported individually. Dr. Paslin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 35 procedures of melanoma (skin cancer) excision by Dr. Paslin, more than 82% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Paslin, published from 2014 to 2021. The most frequent topics are Dermatitis, Atopic and Skin. Dr. Paslin has published most often in Arch Dermatol.

CMS Open Payments shows 265 general payments to Dr. Paslin from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,095.

Dmand AI lists 2 awards for Dr. Paslin, most recently Regional Top Doctor in 2014.

Dr. Paslin graduated from David Geffen School of Medicine at UCLA in 1967. Dr. Paslin is a member of AAD.

Dr. Paslin is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.